Spesolimab

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 219 publications

Spesolimab successfully treated acute generalized exanthematous pustulosis in an IL36RN-postive patient.

Spesolimab successfully treated acute generalized exanthematous pustulosis in an IL36RN-postive patient.

Journal: JAAD case reports
Published: May 25, 2026

IL-36-Driven Inflammation in Generalized Pustular Psoriasis: Immunological Insights from Plaque Psoriasis and Implications for Targeted Therapy.

IL-36-Driven Inflammation in Generalized Pustular Psoriasis: Immunological Insights from Plaque Psoriasis and Implications for Targeted Therapy.

Journal: International journal of molecular sciences
Published: April 17, 2026

The Role of Genetic Testing in the Differential Diagnosis of Pustular Dermatoses: A Pediatric Case of Generalized Pustular Psoriasis Associated with the IL36RN Variant.

The Role of Genetic Testing in the Differential Diagnosis of Pustular Dermatoses: A Pediatric Case of Generalized Pustular Psoriasis Associated with the IL36RN Variant.

Journal: Journal of clinical medicine
Published: April 08, 2026

Successful use of spesolimab in refractory pyoderma gangrenosum.

Successful use of spesolimab in refractory pyoderma gangrenosum.

Journal: JAAD case reports
Published: March 20, 2026

A case of delayed-onset postoperative pyoderma gangrenosum complicated with chronic myelomonocytic leukemia treated with systemic corticosteroids and spesolimab.

A case of delayed-onset postoperative pyoderma gangrenosum complicated with chronic myelomonocytic leukemia treated with systemic corticosteroids and spesolimab.

Journal: JAAD case reports
Published: March 02, 2026

Subcutaneous Spesolimab for Amicrobial Pustulosis of the Folds.

Subcutaneous Spesolimab for Amicrobial Pustulosis of the Folds.

Journal: International journal of dermatology
Published: February 25, 2026

Correction to "Successful Treatment With Spesolimab in a Haemodialysis Patient With Acutely Flaring Generalised Pustular Psoriasis".

Correction to "Successful Treatment With Spesolimab in a Haemodialysis Patient With Acutely Flaring Generalised Pustular Psoriasis".

Journal: JEADV clinical practice
Published: February 25, 2026

Generalized Pustular Psoriasis: Current Treatment and Innovative Therapies.

Generalized Pustular Psoriasis: Current Treatment and Innovative Therapies.

Journal: Cureus
Published: February 09, 2026

Role and clinical significance of PD-L1+ neutrophils in generalized pustular psoriasis

Role and clinical significance of PD-L1+ neutrophils in generalized pustular psoriasis

Journal: Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology
Published: February 01, 2026

Generalized Pustular Psoriasis in Portugal: Expert Perspectives on Patient Journey, Diagnosis, Therapeutic Goals, and Healthcare Optimization.

Generalized Pustular Psoriasis in Portugal: Expert Perspectives on Patient Journey, Diagnosis, Therapeutic Goals, and Healthcare Optimization.

Journal: Acta medica portuguesa
Published: January 23, 2026

Targeting the IL-36 Pathway: Spesolimab as a Therapeutic for Acute Flares of Pustular Psoriasis.

Targeting the IL-36 Pathway: Spesolimab as a Therapeutic for Acute Flares of Pustular Psoriasis.

Journal: Cureus
Published: January 23, 2026

The Relative Efficacy of Monotherapies for Palmoplantar Pustulosis and Palmoplantar Psoriasis: A Network Meta-Analysis Study of the Palmoplantar Spectrum.

The Relative Efficacy of Monotherapies for Palmoplantar Pustulosis and Palmoplantar Psoriasis: A Network Meta-Analysis Study of the Palmoplantar Spectrum.

Journal: Medicina (Kaunas, Lithuania)
Published: January 19, 2026
Showing 1-12 of 219

Last Updated: 06/30/2026